Foghorn Therapeutics Inc. SEC filings FHTX

Foghorn Therapeutics Inc. has 354 filings in SEC EDGAR's recent list, going back to Aug 28, 2020. Its latest annual report, Form ARS, was filed on Apr 30, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Aug 6, 2026, covering the quarter ended Jun 30, 2026. The most recent current report (Form 8-K) was filed on Oct 1, 2026 (exit or restructuring costs, regulation fd disclosure). The company's fiscal year ends on December 31.

Foghorn Therapeutics Inc. SEC filings
Form Description Filed Period
3 Initial insider ownership Oct 5, 2026 Oct 1, 2026
SCHEDULE 13G/A Amended ownership over 5% (passive) Oct 5, 2026 —
8-K Current report
Exit or restructuring costs, Regulation FD disclosure
Oct 1, 2026 Sep 25, 2026
10-Q Quarterly report Aug 6, 2026 Jun 30, 2026
8-K Current report
Results of operations, Regulation FD disclosure
Aug 6, 2026 Aug 6, 2026
4 Insider transaction Jun 25, 2026 Jun 24, 2026
4 Insider transaction Jun 25, 2026 Jun 24, 2026
4 Insider transaction Jun 25, 2026 Jun 24, 2026
4 Insider transaction Jun 25, 2026 Jun 24, 2026
4 Insider transaction Jun 25, 2026 Jun 24, 2026
4 Insider transaction Jun 25, 2026 Jun 24, 2026
4 Insider transaction Jun 25, 2026 Jun 24, 2026
4 Insider transaction Jun 25, 2026 Jun 24, 2026
4 Insider transaction Jun 25, 2026 Jun 24, 2026
8-K Current report
Shareholder vote results
Jun 24, 2026 Jun 24, 2026
SCHEDULE 13G/A Amended ownership over 5% (passive) May 15, 2026 —
SCHEDULE 13G/A Amended ownership over 5% (passive) May 14, 2026 —
10-Q Quarterly report May 7, 2026 Mar 31, 2026
8-K Current report
Results of operations, Regulation FD disclosure
May 7, 2026 May 7, 2026
SCHEDULE 13G/A Amended ownership over 5% (passive) May 6, 2026 —
ARS Annual report to shareholders Apr 30, 2026 Dec 31, 2025
DEFA14A Additional proxy material Apr 30, 2026 —
DEF 14A Proxy statement Apr 30, 2026 Jun 24, 2026
8-K Current report
Regulation FD disclosure, Other events
Apr 21, 2026 Apr 21, 2026
4 Insider transaction Apr 13, 2026 Apr 9, 2026
S-8 Employee stock plan registration Mar 26, 2026 —
10-K Annual report Mar 11, 2026 Dec 31, 2025
8-K Current report
Results of operations, Regulation FD disclosure
Mar 11, 2026 Mar 11, 2026
4 Insider transaction Feb 24, 2026 Feb 23, 2026
3 Initial insider ownership Feb 24, 2026 Feb 23, 2026
8-K Current report
Officer or director change, Other events
Feb 23, 2026 Feb 23, 2026
4 Insider transaction Feb 6, 2026 Feb 5, 2026
4 Insider transaction Feb 2, 2026 Jan 30, 2026
4 Insider transaction Feb 2, 2026 Jan 30, 2026
4 Insider transaction Feb 2, 2026 Jan 30, 2026
4 Insider transaction Feb 2, 2026 Jan 30, 2026
4 Insider transaction Feb 2, 2026 Jan 30, 2026
4 Insider transaction Jan 15, 2026 Jan 13, 2026
SCHEDULE 13D/A Amended ownership over 5% (active) Jan 13, 2026 —
424B5 Prospectus supplement Jan 12, 2026 —
8-K Current report
Results of operations, Regulation FD disclosure, Other events
Jan 12, 2026 Jan 9, 2026
8-K Current report
Officer or director change
Dec 4, 2025 Dec 3, 2025
4 Insider transaction Nov 17, 2025 Nov 14, 2025
8-K Current report
Regulation FD disclosure
Nov 7, 2025 Nov 7, 2025
10-Q Quarterly report Nov 5, 2025 Sep 30, 2025
8-K Current report
Results of operations, Officer or director change, Regulation FD disclosure
Nov 5, 2025 Nov 5, 2025
8-K Current report
Regulation FD disclosure, Other events
Oct 30, 2025 Oct 30, 2025
8-K Current report
Regulation FD disclosure
Sep 2, 2025 Sep 2, 2025
10-Q Quarterly report Aug 5, 2025 Jun 30, 2025
8-K Current report
Results of operations, Regulation FD disclosure
Aug 5, 2025 Aug 5, 2025
8-K Current report
Material agreement, Agreement ended
Jul 1, 2025 Jun 27, 2025
4 Insider transaction Jun 17, 2025 Jun 17, 2025
4 Insider transaction Jun 17, 2025 Jun 17, 2025
4 Insider transaction Jun 17, 2025 Jun 17, 2025
4 Insider transaction Jun 17, 2025 Jun 17, 2025
4 Insider transaction Jun 17, 2025 Jun 17, 2025
4 Insider transaction Jun 17, 2025 Jun 17, 2025
4 Insider transaction Jun 17, 2025 Jun 17, 2025
8-K Current report
Shareholder vote results
Jun 17, 2025 Jun 17, 2025
10-Q Quarterly report May 14, 2025 Mar 31, 2025
8-K Current report
Results of operations, Regulation FD disclosure
May 14, 2025 May 14, 2025
ARS Annual report to shareholders May 5, 2025 Dec 31, 2024
DEFA14A Additional proxy material May 5, 2025 —
DEF 14A Proxy statement May 5, 2025 Jun 17, 2025
4 Insider transaction May 2, 2025 May 1, 2025
4 Insider transaction May 2, 2025 May 1, 2025
3 Initial insider ownership May 2, 2025 May 1, 2025
3 Initial insider ownership May 2, 2025 May 1, 2025
8-K Current report
Officer or director change, Other events
May 1, 2025 Apr 25, 2025
8-K Current report
Regulation FD disclosure, Other events
Apr 28, 2025 Apr 28, 2025
4 Insider transaction Apr 28, 2025 Apr 25, 2025
4 Insider transaction Apr 10, 2025 Apr 9, 2025
8-K Current report
Regulation FD disclosure
Mar 24, 2025 Mar 24, 2025
8-K Current report
Other events
Mar 20, 2025 Mar 20, 2025
424B5 Prospectus supplement Mar 20, 2025 —
10-K Annual report Mar 6, 2025 Dec 31, 2024
8-K Current report
Results of operations
Mar 6, 2025 Mar 6, 2025
SCHEDULE 13G/A Amended ownership over 5% (passive) Feb 12, 2025 —
8-K Current report
Regulation FD disclosure
Feb 3, 2025 Feb 3, 2025
EFFECT Filing Jan 31, 2025 —
CORRESP Letter to the SEC Jan 29, 2025 —
UPLOAD Letter from the SEC Jan 29, 2025 —
4 Insider transaction Jan 24, 2025 Jan 22, 2025
4 Insider transaction Jan 24, 2025 Jan 22, 2025
4 Insider transaction Jan 24, 2025 Jan 22, 2025
4 Insider transaction Jan 24, 2025 Jan 22, 2025
4 Insider transaction Jan 24, 2025 Jan 22, 2025
4 Insider transaction Jan 24, 2025 Jan 22, 2025
4 Insider transaction Jan 24, 2025 Jan 22, 2025
S-3 Shelf registration Jan 24, 2025 —
S-8 Employee stock plan registration Jan 24, 2025 —
8-K Current report
Listing notice
Jan 24, 2025 Jan 23, 2025
8-K Current report
Results of operations, Regulation FD disclosure
Jan 13, 2025 Jan 13, 2025
4 Insider transaction Dec 30, 2024 Dec 29, 2024
8-K Current report
Officer or director change
Dec 30, 2024 Dec 29, 2024
8-K Current report
Regulation FD disclosure, Other events
Dec 16, 2024 Dec 16, 2024
10-Q Quarterly report Nov 4, 2024 Sep 30, 2024
8-K Current report
Results of operations, Regulation FD disclosure
Nov 4, 2024 Nov 4, 2024
8-K Current report
Regulation FD disclosure, Other events
Oct 10, 2024 Oct 10, 2024
SC 13G/A Amended ownership over 5% (passive) Oct 8, 2024 —
4 Insider transaction Sep 24, 2024 Sep 20, 2024
SC 13G Ownership over 5% (passive) Sep 20, 2024 —
4 Insider transaction Sep 20, 2024 Sep 18, 2024
4 Insider transaction Sep 18, 2024 Sep 16, 2024
144 Notice of proposed sale Sep 16, 2024 —
4 Insider transaction Sep 11, 2024 Sep 9, 2024
144 Notice of proposed sale Sep 9, 2024 —
4 Insider transaction Sep 4, 2024 Sep 3, 2024
3 Initial insider ownership Sep 4, 2024 Sep 3, 2024
424B5 Prospectus supplement Aug 8, 2024 —
10-Q Quarterly report Aug 8, 2024 Jun 30, 2024
8-K Current report
Results of operations, Regulation FD disclosure
Aug 8, 2024 Aug 8, 2024
4 Insider transaction Jun 28, 2024 Jun 26, 2024
4 Insider transaction Jun 28, 2024 Jun 26, 2024
4 Insider transaction Jun 28, 2024 Jun 26, 2024
4 Insider transaction Jun 28, 2024 Jun 26, 2024
4 Insider transaction Jun 28, 2024 Jun 26, 2024
4 Insider transaction Jun 28, 2024 Jun 26, 2024
4 Insider transaction Jun 28, 2024 Jun 26, 2024
4 Insider transaction Jun 28, 2024 Jun 26, 2024
8-K Current report
Shareholder vote results
Jun 26, 2024 Jun 26, 2024
4 Insider transaction Jun 24, 2024 Jun 21, 2024
SC 13G/A Amended ownership over 5% (passive) Jun 10, 2024 —
8-K Current report
Regulation FD disclosure
Jun 3, 2024 Jun 3, 2024
SC 13G Ownership over 5% (passive) May 30, 2024 —
4 Insider transaction May 24, 2024 May 22, 2024
SC 13D/A Amended ownership over 5% (active) May 24, 2024 —
3 Initial insider ownership May 24, 2024 May 22, 2024
8-K Current report
Regulation FD disclosure
May 23, 2024 May 23, 2024
8-K Current report
Material agreement, Other events
May 22, 2024 May 20, 2024
424B5 Prospectus supplement May 20, 2024 —
8-K Current report
Regulation FD disclosure
May 20, 2024 May 20, 2024
8-K Current report
Other events
May 6, 2024 May 6, 2024
10-Q Quarterly report May 6, 2024 Mar 31, 2024
S-8 Employee stock plan registration May 6, 2024 —
8-K Current report
Results of operations, Other events
May 6, 2024 May 6, 2024
ARS Annual report to shareholders May 3, 2024 Dec 31, 2023
DEFA14A Additional proxy material May 3, 2024 —
DEF 14A Proxy statement May 3, 2024 Jun 26, 2024
4 Insider transaction Apr 17, 2024 Apr 16, 2024
3 Initial insider ownership Apr 17, 2024 Apr 16, 2024
8-K Current report
Officer or director change, Other events
Apr 16, 2024 Apr 16, 2024
8-K Current report
Regulation FD disclosure, Other events
Apr 9, 2024 Apr 9, 2024
4 Insider transaction Mar 12, 2024 Mar 11, 2024
8-K Current report
Results of operations, Regulation FD disclosure
Mar 7, 2024 Mar 7, 2024
10-K Annual report Mar 7, 2024 Dec 31, 2023
SC 13G/A Amended ownership over 5% (passive) Feb 9, 2024 —
8-K Current report
Regulation FD disclosure, Other events
Feb 8, 2024 Feb 8, 2024
4 Insider transaction Jan 25, 2024 Jan 24, 2024
4 Insider transaction Jan 25, 2024 Jan 24, 2024
4 Insider transaction Jan 25, 2024 Jan 24, 2024
4 Insider transaction Jan 25, 2024 Jan 24, 2024
4 Insider transaction Jan 25, 2024 Jan 24, 2024
4 Insider transaction Jan 25, 2024 Jan 24, 2024
8-K Current report
Officer or director change
Jan 17, 2024 Jan 16, 2024
4 Insider transaction Jan 17, 2024 Jan 16, 2024
8-K Current report
Regulation FD disclosure
Jan 8, 2024 Jan 8, 2024
8-K Current report
Officer or director change
Jan 3, 2024 Dec 29, 2023
4 Insider transaction Dec 12, 2023 Dec 8, 2023
10-Q Quarterly report Nov 2, 2023 Sep 30, 2023
8-K Current report
Results of operations, Regulation FD disclosure
Nov 2, 2023 Nov 2, 2023
4 Insider transaction Sep 13, 2023 Sep 11, 2023
4 Insider transaction Sep 13, 2023 Sep 11, 2023
3 Initial insider ownership Sep 13, 2023 Sep 11, 2023
8-K Current report
Regulation FD disclosure
Sep 8, 2023 Sep 8, 2023
8-K Current report
Other events
Aug 31, 2023 Aug 31, 2023
4 Insider transaction Aug 18, 2023 Aug 16, 2023
4 Insider transaction Aug 18, 2023 Aug 17, 2023
144 Notice of proposed sale Aug 16, 2023 —
8-K Current report
Agreement ended
Aug 10, 2023 Aug 9, 2023
8-K Current report
Other events
Aug 8, 2023 Aug 3, 2023
10-Q Quarterly report Aug 4, 2023 Jun 30, 2023
8-K Current report
Results of operations, Regulation FD disclosure
Aug 4, 2023 Aug 4, 2023
8-K Current report
Regulation FD disclosure, Other events
Jun 28, 2023 Jun 28, 2023
4 Insider transaction Jun 22, 2023 Jun 21, 2023
4 Insider transaction Jun 22, 2023 Jun 21, 2023
4 Insider transaction Jun 22, 2023 Jun 21, 2023
4 Insider transaction Jun 22, 2023 Jun 21, 2023
4 Insider transaction Jun 22, 2023 Jun 21, 2023
4 Insider transaction Jun 22, 2023 Jun 21, 2023
4 Insider transaction Jun 22, 2023 Jun 21, 2023
4 Insider transaction Jun 22, 2023 Jun 21, 2023
8-K Current report
Shareholder vote results
Jun 22, 2023 Jun 21, 2023
8-K Current report
Regulation FD disclosure, Other events
Jun 5, 2023 Jun 1, 2023
4 Insider transaction May 31, 2023 May 26, 2023
S-8 Employee stock plan registration May 8, 2023 —
10-Q Quarterly report May 8, 2023 Mar 31, 2023
8-K Current report
Results of operations, Regulation FD disclosure
May 8, 2023 May 8, 2023
ARS Annual report to shareholders Apr 28, 2023 Dec 31, 2022
DEFA14A Additional proxy material Apr 28, 2023 —
DEF 14A Proxy statement Apr 28, 2023 Jun 21, 2023
8-K Current report
Other events
Apr 24, 2023 Apr 24, 2023
10-K Annual report Mar 9, 2023 Dec 31, 2022
8-K Current report
Results of operations, Regulation FD disclosure
Mar 9, 2023 Mar 7, 2023
8-K Current report
Regulation FD disclosure
Mar 8, 2023 Mar 8, 2023
4 Insider transaction Feb 22, 2023 Feb 10, 2022
SC 13G/A Amended ownership over 5% (passive) Feb 9, 2023 —
4 Insider transaction Jan 30, 2023 Jan 26, 2023
4 Insider transaction Jan 30, 2023 Jan 26, 2023
4 Insider transaction Jan 30, 2023 Jan 26, 2023

Showing 200 filings, the most recent 200. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.

Company profile

Industry
Pharmaceutical Preparations (SIC 2834)
Listed as
FHTX (Nasdaq)
Fiscal year ends
December 31
Incorporated in
DE
Headquarters
Cambridge, MA
SEC filer status
Non-accelerated filer, Smaller reporting company
SEC CIK
1822462

Other Pharmaceutical Preparations companies

Source: SEC EDGAR filings. This is company-reported data, not investment advice.